Title	Publication Date	Language	Citations
Dysregulated Innate Immune Responses in Young Children with Autism Spectrum Disorders: Their Relationship to Gastrointestinal Symptoms and Dietary Intervention	2005/01/01	English	124
(±)3,4-Methylenedioxymethamphetamine (‘Ecstasy’)-Induced Serotonin Neurotoxicity: Clinical Studies	2000/01/01	English	124
Neurochemical Substrates and Neuroanatomical Generators of the Event-Related P300	1999/01/01	English	124
Common and Distinct Brain Activation to Threat and Safety Signals in Social Phobia	2005/01/01	English	123
Antioxidant Enzyme Activities and Malondialdehyde Levels in Patients with Obsessive-Compulsive Disorder	2002/01/01	English	121
Attenuated Left Prefrontal Activation during a Verbal Fluency Task in Patients with Depression	2003/01/01	English	119
Diffusion Tensor Magnetic Resonance Imaging of Disruption of Regional White Matter in Schizophrenia	2003/01/01	English	117
Effects of the Serotonin Type 2A, 3A and 3B Receptor and the Serotonin Transporter Genes on Paroxetine and Fluvoxamine Efficacy and Adverse Drug Reactions in Depressed Japanese Patients	2006/01/01	English	112
Model-Based and Model-Free Decisions in Alcohol Dependence	2014/01/01	English	112
The Psychobiological Model for Impulsive Unsocialized Sensation Seeking: A Comparative Approach	1996/01/01	English	108
Noradrenergic Mechanisms in the Pathophysiology of Post-Traumatic Stress Disorder	2004/01/01	English	106
Healthy and Pathological Brain Aging: From the Perspective of Oscillations, Functional Connectivity, and Signal Complexity	2017/01/01	English	103
Is MDMA (‘Ecstasy’) Neurotoxic in Humans? An Overview of Evidence and of Methodological Problems in Research	2000/01/01	English	102
Influence of Mindfulness Practice on Cortisol and Sleep in Long-Term and Short-Term Meditators	2012/01/01	English	102
Guidelines for the Recording and Evaluation of Pharmaco-EEG Data in Man: The International Pharmaco-EEG Society (IPEG)	2012/01/01	English	102
Cytokine Changes and Tryptophan Metabolites in Medication-Naïve and Medication-Free Schizophrenic Patients	2009/01/01	English	101
A Randomised Study Comparing Escitalopram with Venlafaxine XR in Primary Care Patients with Major Depressive Disorder	2004/01/01	English	101
Neuroendocrine Responses to Psychological Stress in Adolescents with Anxiety Disorder	2000/01/01	English	100
Antioxidant Enzyme and Malondialdehyde Levels in Patients with Panic Disorder	2002/01/01	English	100
Propofol-Induced Alpha Rhythm	2004/01/01	English	99
Gabapentin versus Ropinirole in the Treatment of Idiopathic Restless Legs Syndrome	2003/01/01	English	98
Pharmacological Characterisation of a Modified Social Interaction Model of Anxiety in the Rat	1985/01/01	English	97
Human Research on MDMA (3,4-Methylene- dioxymethamphetamine) Neurotoxicity: Cognitive and Behavioural Indices of Change	2000/01/01	English	97
Plasma Brain-Derived Neurotrophic Factor as a Peripheral Marker for the Action Mechanism of Antidepressants	2008/01/01	English	96
Meta-Analysis of the Brain-Derived Neurotrophic Factor Gene <i>(BDNF)</i> Val66Met Polymorphism in Anxiety Disorders and Anxiety-Related Personality Traits	2008/01/01	English	96
Tryptophan Metabolism and Related Pathways in Psychoneuroimmunology: The Impact of Nutrition and Lifestyle	2019/02/26	English	95
Changes in Acute-Phase Proteins during Lithium Potentiation of Antidepressants in Refractory Depression	1997/01/01	English	95
Topographical Analysis of Sleep Spindle Activity	1992/01/01	English	95
Animal Models for Predicting Clinical Efficacy of Anxiolytic Drugs: Social Behaviour	1985/01/01	English	94
Is Alpha Wave Neurofeedback Effective with Randomized Clinical Trials in Depression? A Pilot Study	2010/11/09	English	93